Insurance Can Decide Survival for Young Cancer Patients
April 2, 2026
Brand Name :
Anascorp
Synonyms :
antivenins, centuroides (scorpion)
Class :
Antivenins
Dosing forms and strengths
Powder for injection
<120 mg total protein and >150 LD50 [mouse] neutralizing units/vial
Indicated for Centruroides (Scorpion) Envenomation
The initial dose entails administering the contents of three vials intravenously in a ten-minute infusion while closely monitoring the patient for up to an hour after completing the infusion to evaluate symptom resolution
Powder for injection
<120mg total protein and >150 LD50 [mouse] neutralizing units/vial
Indicated for Centruroides (Scorpion) Envenomation
Administer the first dose by intravenous infusion of the contents of three vials over a period of ten minutes while observing the intravenous preparation
Monitor the patient for up to 60 minutes after the infusion is complete to determine if any symptoms have been alleviated If necessary
additional doses may be given, with each vial being infused individually at 30-60 minute intervals
It should be noted that the majority of patients who participated in the clinical trials were children, comprising 78% of the study group and ranging in age from less than one month to 18.7 years old
Refer adult dosing
Actions and Spectrum:
The action of antivenin centruroides is to bind to the toxins produced by the scorpion’s venom and neutralize them, preventing them from causing harm to the body. The antivenin works by introducing a large amount of antibodies into the bloodstream, which bind to the venom and prevent it from interacting with the body’s tissues and organs.
The spectrum of antivenin centruroides is specific to the venom of the centruroides species of scorpion, which is found in the southwestern United States and in parts of Mexico. It is not effective against the venom of other scorpion species. The antivenin is typically administered intravenously, and its effects can be seen within minutes after administration.
Frequency defined
Adults
1-10%
Rhinorrhea (1.8%)
Myalgia (1.6%)
Fatigue (1.6%)
Cough (1.4%)
Rash (2.7%)
Nausea (2.1%)
Pruritus (2%)
Headache (1.9%)
Vomiting (4.7%)
Pyrexia (4.1%)
<1%
Serum sickness (0.5%)
Black Box Warning:
serious allergic reactions: allergic severe including anaphylaxis, may occur in patients treated with centruroides (scorpion) antivenin. In some cases, these reactions can be life-threatening or fatal. Patients should be carefully monitored for signs of allergic reactions during and after administration of the antivenin, including but not limited to skin rash, hives, itching, swelling, difficulty breathing, and/or hypotension.
If an allergic reaction occurs, the antivenin infusion should be immediately discontinued and appropriate medical treatment should be initiated. Only administer centruroides (scorpion) antivenin in a healthcare setting with appropriate monitoring and resuscitation equipment. Healthcare providers should be trained in the recognition and management of serious allergic reactions.
Prior to administration, patients evaluated for a history of allergy, including prior exposure to antivenin or similar products. The potential benefits of treatment with centruroides (scorpion) antivenin should be weighed against the risk of severe allergic reactions in each individual patient.
Contraindication/Caution:
Allergy: People who have a known allergy to horse serum or equine products should not receive this antivenin as it is made from horse serum.
Delayed administration: The antivenin may not be effective if it is administered more than 6 hours after the sting.
Previous reactions: People who have had previous reactions to antivenin centruroides should not receive it again.
Other medications: Some medications, such as ACE inhibitors and beta-blockers, may interfere with the effectiveness of antivenin centruroides.
Pregnancy and breastfeeding: The safety of antivenin centruroides has not been established in pregnant or breastfeeding women.
Children under six months: The safety and effectiveness of antivenin centruroides in children under six months old have not been established.
Pregnancy warnings:
Pregnancy category: N/A
Lactation: Excreted into human milk is unknown
Pregnancy Categories:
Category A: Studies that were well-controlled and met expectations revealed no risk to the fetus in the first or second trimester.
Category B: There were a lack of studies on pregnant women and no evidence of risk to the fetus in animal experiments.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Pharmacology:
antivenin is a medication used to treat envenomation caused by scorpion stings. Specifically, centruroides antivenin is used to treat envenomation caused by scorpion stings
Pharmacodynamics:
The pharmacodynamics mechanism of antivenin, centruroides involves neutralizing the toxic components of scorpion venom and preventing them from causing further harm to the patient.
MOA:
The mechanism of action of antivenin against centruroides scorpion venom involves a process called neutralization.
Neutralization occurs when the antivenin binds to the toxic molecules in the venom and renders them inactive. This binding process is particular, meaning that the antivenin can only neutralize the venom from the specific type of scorpion it was created for.
Pharmacokinetics:
Absorption:
antivenin centruroides is administered intravenously, meaning that it is directly introduced into the bloodstream. This allows for rapid absorption and distribution throughout the body.
Distribution:
Once in the bloodstream, the antivenom is distributed to the areas most needed. It binds to the venom molecules and neutralizes their effects, preventing further damage to the body.
Metabolism:
antivenin centruroides is not metabolized in the body. Instead, it works by binding to the venom molecules and rendering them harmless.
Excretion and excretion:
The body excretes antivenin centruroides through the kidneys. medication’s half-life is approximately 10 hours, meaning that it takes about 10 hours for the body to eliminate half of the drug from the bloodstream.
Administration:
The healthcare professional will assess the patient’s vital signs and symptoms, and confirm the presence of scorpion sting.
The antivenin may be given as an intravenous infusion or intramuscular injection.
Before administering the antivenin, the healthcare professional may test the patient for hypersensitivity or allergic reactions to the antivenin.
If there is no hypersensitivity or allergic reaction, the antivenin is administered.
After administration of antivenin, the patient’s vital signs, symptoms, and any adverse reactions will be monitored closely for a period of time.
The healthcare professional may administer additional doses of antivenin if the patient’s symptoms do not improve or if new symptoms arise.
If the patient experiences severe allergic reactions or anaphylaxis, the healthcare professional will immediately administer medications such as epinephrine, antihistamines, and corticosteroids to manage the symptoms.
Patient information leaflet
Generic Name: antivenins, centuroides (scorpion)
Why do we use?
antivenins, centuroides (scorpion)
antivenom is used to treat the symptoms of envenomation, or the injection of venom into the body by an animal such as a scorpion. centruroides scorpions are known to be particularly venomous and can cause severe symptoms in humans, including intense pain, muscle spasms, and respiratory distress.
antivenom is created by injecting a small amount of the venom into animals, such as horses or sheep, in a controlled setting. The animals produce antibodies to the venom, which are then harvested and processed into a serum that can be used to treat envenomation.
When administered to an envenomated person, the antivenom works by binding to the venom molecules and neutralizing their effects. This can help alleviate the symptoms of envenomation and prevent further damage to the body.